Northern Trust announces key executive appointments aimed at strengthening its Canadian asset servicing footprint and accelerating the adoption of artificial intelligence across its investment management operations, signaling a strategic pivot amid strong stock performance.
A UK tribunal has allowed a massive lawsuit accusing Valve of anti-competitive practices to proceed, drawing vocal support from Epic Games CEO Tim Sweeney, who calls Steam the last major platform clinging to restrictive payment rules.
The consumer goods giant Kimberly-Clark announced a dividend increase to $1.28 per share, lifting its yield above 5%. However, the move comes against a backdrop of declining earnings, casting doubt on the long-term sustainability of its shareholder returns.
While Exelon's recent earnings beat expectations, the utility giant continues to face investor skepticism over its long-term growth trajectory. Wall Street maintains a guarded optimism, but the stock's performance tells a more nuanced story.
Shares of the staffing leader surged after its Q4 earnings hinted at a potential end to a multi-year slump, with management pointing to positive sequential growth for the first time since 2021.
The doughnut giant has agreed to a multimillion-dollar settlement following a 2024 cyberattack that compromised personal data of current and former staff, though it admits no fault.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
Walmart is significantly expanding its electric vehicle charging infrastructure, with planned installations at select stores across 19 states, advancing its goal to build a nationwide network by 2030.
BlackRock has increased its stake in the diversified precious metals miner Sibanye-Stillwater beyond 5%, signaling strong institutional confidence amid a historic rally in gold and platinum group metals. We examine the drivers behind the surge and what it means for investors.
Insulet (PODD) shares have faced significant pressure in recent months, diverging from the company's underlying business performance. This analysis delves into whether the current price weakness presents a buying opportunity for the Omnipod maker or reflects deeper market concerns about its premium valuation and growth sustainability.
Netflix's unprecedented all-cash offer to acquire Warner Bros. Discovery has sent shockwaves through the media industry, setting the stage for a fierce regulatory battle and raising fundamental questions about the streaming giant's financial strategy and market dominance.
Social media investigations reveal widespread weight mislabeling on Walmart meat products, prompting potential legal action and raising questions about pricing integrity at the retail giant.
Amidst economic crosscurrents, a closer look at Ideal Power, NetSol Technologies, and Sono-Tek reveals companies executing distinct strategies to navigate growth and profitability challenges in the high-risk, high-reward penny stock arena.
From innovative financing for indie labels to major acquisitions in live events, the music business landscape is being reshaped by a series of strategic partnerships and investments unveiled over the past fortnight.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
While major indices hold steady, a search for growth is turning the spotlight onto smaller companies. We examine three small-cap stocks—from insurance to banking to luxury watches—that are posting strong results and navigating unique challenges in the current market.
As markets swing between optimism and caution, income-focused investors are turning to dividend payers for potential stability. We analyze three stocks offering yields from 3.5% to over 10%, each with a distinct risk and reward profile.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
